March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Upregulation Of TGF-ß1 In Experimental Proliferative Vitreoretinopathy Is Accompanied By Epithelial To Mesenchymal Transition
Author Affiliations & Notes
  • Robert Hoerster
    Department of Vitreoretinal Surgery, University of Cologne, Cologne, Germany
  • Philipp S. Muether
    Department of Vitreoretinal Surgery, University of Cologne, Cologne, Germany
  • Bernd Kirchhof
    Department of Vitreoretinal Surgery, University of Cologne, Cologne, Germany
  • Sascha Fauser
    Department of Vitreoretinal Surgery, University of Cologne, Cologne, Germany
  • Footnotes
    Commercial Relationships  Robert Hoerster, None; Philipp S. Muether, None; Bernd Kirchhof, None; Sascha Fauser, None
  • Footnotes
    Support  Köln Fortune Project-No. 08/2011
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 891. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Robert Hoerster, Philipp S. Muether, Bernd Kirchhof, Sascha Fauser; Upregulation Of TGF-ß1 In Experimental Proliferative Vitreoretinopathy Is Accompanied By Epithelial To Mesenchymal Transition. Invest. Ophthalmol. Vis. Sci. 2012;53(14):891.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Proliferative vitreoretinopathy (PVR) is characterized by the formation of fibrous membranes, leading to retinal redetachments after vitreoretinal surgery. Retinal pigment epithelium cells (RPE cells) are key players in the pathogenesis of PVR. They undergo epithelial to mesenchymal transition (EMT) to form myofibroblasts expressing vimentin as an intracellular protein. The isoforms 1 and 2 of transforming growth factor beta (TGF-ß) promote fibrosis via induction of EMT. TGF-ß3 inhibits fibrosis. To estimate the role of TGF-ß isoforms in the pathogenesis of PVR we analysed TGF-ß1, 2 and 3 during the course of experimental PVR.

Methods: : Female, pigmented rabbits (chinchilla bastard) were treated with 180° circumferential retinal cryopexy, followed by a 6mm full-thickness incision 3mm posterior to the limbus. Wound treatment was conducted using biodegradable sutures. Animals were examined for 28 days (d) using indirect ophthalmoscopy. Anterior chamber (AC) and vitreous samples were obtained at d0 and at d28. After sacrification on d28 the eyes were removed and flatmounted for PVR grading. Complete retinal and choroidal tissue-samples were obtained for detection of vimentin by western blot. TGF-ß isoform concentrations were determined by multiplex bead assay analysis.

Results: : PVR was induced in all treated eyes (n=6). None of the eyes suffered from intraocular infection. The number of quadrants affected by PVR was 1 (n=3), 2 (n=1), 3 (n=2). TGF-ß1 levels in native eyes were 5.4pg/ml ± 12.0 (AC) and 232.2pg/ml ± 391.1 (vitreous). TGF-ß2 levels in native eyes were 979.3pg/ml ± 48.7 (AC) and 9195.2pg/ml ± 3219.1 (vitreous). During PVR development TGF-ß1 levels increased significantly to 352.8±484.3 (AC) and 1369.2pg/ml ± 1057.3 (vitreous) (p=0.028). TGF-ß2 levels increased to 1655.3±757.1 (AC) and 16134.4pg/ml ± 10348.1 (vitreous). The increase in TGF-ß2 was not significant. TGF-ß3 was not detected at any timepoint. TGF-ß1 but not TGF-ß2 levels in vitreous and AC corresponded well with the amount of PVR and vimentin expression.

Conclusions: : The PVR-dependent upregulation of TGF-ß1, and to a lesser extent of TGF-ß2 corresponding to expression of the EMT-marker vimentin may indicate a pivotal role of TGF-ß1 in formation of PVR membranes. TGF-ß1 could therefore be a promising target for inhibition of PVR.

Keywords: proliferative vitreoretinopathy • growth factors/growth factor receptors • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×